Both in Pharmaceuticals
Acadia Pharmaceuticals vs Xenon Pharmaceuticals
Over the past year ACAD returned −8.0% and XENE returned −7.0%; their daily moves had a correlation of 0.23.
ACAD −8.0% XENE −7.0%Growth of $1, one year, split-adjusted
| Metric | ACAD | XENE |
|---|---|---|
| Price | $20.57 | $38.23 |
| Market cap | $3.54B | $3.70B |
| Today | +0.49% | +1.62% |
| 1 month | +2.3% | +1.8% |
| 6 months | −8.0% | −33.8% |
| Year to date | −23.0% | −14.7% |
| 1 year | −9.4% | −8.8% |
| Revenue growth (YoY) | +16.4% | — |
| Gross margin | 90.8% | — |
| Net margin | 10.2% | — |
| P/E (TTM) | 9.3× | — |
| Price / sales | 3.1× | — |
| Net cash | $956.5M | $930.7M |
| Dividend yield | — | — |
| Volatility (60d) | 43.8% | 82.4% |
| Short % of float | 7.1% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).